• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Biosimilars: what the oncologist should know

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Thill, M
    Thatcher, Nick
    Hanes, V
    Lyman, H
    Affiliation
    Department of Medical Oncology, Gustave Roussy, Villejuif, France
    Issue Date
    2019
    
    Metadata
    Show full item record
    Abstract
    As originator biologic medicines lose patent protection, some biopharmaceutical companies are focusing on developing similar versions of these costly and complex therapies with a goal of providing more affordable treatment options. Many of these molecules, known as biosimilars, are now approved worldwide and several more are expected to be introduced in the near future. As more biosimilars become available, it is important for clinicians to become familiar with this new category of products and understand how biosimilars are developed, how their development differs from that of originator biologics and how they differ from generics. This review aims to provide the practicing clinician with the knowledge needed to understand biosimilars, along with some guidance on their use in treating oncologic diseases.
    Citation
    Thill M, Thatcher N, Hanes V, Lyman G. Biosimilars: what the oncologist should know. Future Oncol. 2019.
    Journal
    Future Oncology
    URI
    http://hdl.handle.net/10541/621701
    DOI
    10.2217/fon-2018-0728
    PubMed ID
    30793950
    Additional Links
    https://dx.doi.org/10.2217/fon-2018-0728
    Type
    Article
    Language
    en
    ae974a485f413a2113503eed53cd6c53
    10.2217/fon-2018-0728
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Biosimilar safety considerations in clinical practice.
    • Authors: Choy E, Jacobs IA
    • Issue date: 2014 Feb
    • The Language of Biosimilars: Clarification, Definitions, and Regulatory Aspects.
    • Authors: Declerck P, Danesi R, Petersel D, Jacobs I
    • Issue date: 2017 Apr
    • [Evolution of biologicals in inflammation medicine--biosimilars in gastroenterology, rheumatology and dermatology].
    • Authors: Schreiber S, Luger T, Mittendorf T, Mrowietz U, Müller-Ladner U, Schröder J, Stallmach A, Bokemeyer B
    • Issue date: 2014 Nov
    • Biosimilars: what the dermatologist should know.
    • Authors: Yamauchi P, Crowley J, Kaur P, Spelman L, Warren R
    • Issue date: 2018 Jul
    • Demystifying biosimilars: development, regulation and clinical use.
    • Authors: Rugo HS, Rifkin RM, Declerck P, Bair AH, Morgan G
    • Issue date: 2019 Mar
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.